Michael Tribanek

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 147 citations · Full text

Efficacy and safety of a once‐daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial

Ralf Ihl, N. Bachinskaya, Amos D. Korczyn et al. · International Journal of Geriatric Psychiatry · 2010 · 133 citations

Efficacy and Tolerability of a Once Daily Formulation of Ginkgo biloba Extract EGb 761® in Alzheimer's Disease and Vascular Dementia: Results from a Randomised Controlled Trial

Ralf Ihl, Michael Tribanek, N. Bachinskaya · Pharmacopsychiatry · 2011 · 119 citations · Full text

Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD

H Matthys, Dina A. Pliskevich, O M Bondarchuk et al. · Respiratory Medicine · 2013 · 31 citations · Full text

Eps 7630, Psychiatry, Placebo-controlled Trial +4

Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial

Ralf Ihl, Michael Tribanek, N. Bachinskaya · Journal of the Neurological Sciences · 2010 · 28 citations

Ginkgo Biloba Extract, Effect Modifiers, Neuropsychology +11